(NYSEMKT: CLDI) Calidi Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.82%.
Calidi Biotherapeutics's earnings in 2025 is -$21,575,000.On average, 1 Wall Street analyst forecast CLDI's earnings for 2025 to be -$19,719,343, with the lowest CLDI earnings forecast at -$19,719,343, and the highest CLDI earnings forecast at -$19,719,343.
In 2026, CLDI is forecast to generate -$14,630,412 in earnings, with the lowest earnings forecast at -$14,630,412 and the highest earnings forecast at -$14,630,412.